Ryan Preblick, Chief Financial Officer, on June 08, 2026, sold 36,000 shares in Indivior Pharmaceuticals (INDV) for $1,357,200. Following the Form 4 filing with the SEC, Preblick has control over a total of 284,751 common shares of the company, with 284,751 shares held directly.
SEC Filing:
Greg Swyt, Chief Financial Officer, on June 08, 2026, sold 6,820 shares in Ichor Holdings (ICHR) for $455,644. Following the Form 4 filing with the SEC, Swyt has control over a total of 53,070 ordinary shares of the company, with 53,070 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1652535/000172343326000027/xslF345X05/wk-form4_1781040498.xml
James L. Cunniff, Director, CEO and President, on June 08, 2026, sold 9,700 shares in Electromed (ELMD) for $354,095. Following the Form 4 filing with the SEC, Cunniff has control over a total of 147,751 common shares of the company, with 147,751 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1488917/000143774926020030/xslF345X05/rdgdoc.xml
Sheri Savage, CFO, on June 04, 2026, sold 14,421 shares in Ultra Clean Holdings (UCTT) for $1,289,915. Following the Form 4 filing with the SEC, Savage has control over a total of 66,476 common shares of the company, with 66,476 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1275014/000095010326008737/xslF345X05/ownership.xml